IS7551A - Stilltar lyfjafræðilegar samsetningar sem byggðareru á pólýoxýetýlaðri laxerolíu og aðferð við að framleiða þær - Google Patents

Stilltar lyfjafræðilegar samsetningar sem byggðareru á pólýoxýetýlaðri laxerolíu og aðferð við að framleiða þær

Info

Publication number
IS7551A
IS7551A IS7551A IS7551A IS7551A IS 7551 A IS7551 A IS 7551A IS 7551 A IS7551 A IS 7551A IS 7551 A IS7551 A IS 7551A IS 7551 A IS7551 A IS 7551A
Authority
IS
Iceland
Prior art keywords
producing
pharmaceutical compositions
castor oil
compositions based
polyoxyethylated castor
Prior art date
Application number
IS7551A
Other languages
English (en)
Inventor
Kysilka Vladimir
Zatloukalova Libuse
Zaludek Borek
Pospisilik Karel
Cigankova Marie
Kubat Martin
Cirkva Ales
Original Assignee
Pliva-Lachema A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema A.S. filed Critical Pliva-Lachema A.S.
Publication of IS7551A publication Critical patent/IS7551A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS7551A 2002-06-10 2004-11-25 Stilltar lyfjafræðilegar samsetningar sem byggðareru á pólýoxýetýlaðri laxerolíu og aðferð við að framleiða þær IS7551A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20022027A CZ294371B6 (cs) 2002-06-10 2002-06-10 Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
PCT/EP2003/005153 WO2003103714A1 (en) 2002-06-10 2003-05-16 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same

Publications (1)

Publication Number Publication Date
IS7551A true IS7551A (is) 2004-11-25

Family

ID=29721409

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7551A IS7551A (is) 2002-06-10 2004-11-25 Stilltar lyfjafræðilegar samsetningar sem byggðareru á pólýoxýetýlaðri laxerolíu og aðferð við að framleiða þær

Country Status (19)

Country Link
US (1) US20050142225A1 (is)
EP (1) EP1515751A1 (is)
JP (1) JP2005534656A (is)
KR (1) KR20050010030A (is)
CN (1) CN1655824A (is)
AU (1) AU2003240661A1 (is)
BR (1) BR0311687A (is)
CA (1) CA2487889A1 (is)
CZ (1) CZ294371B6 (is)
EA (1) EA007223B1 (is)
HR (1) HRP20041107A2 (is)
IL (2) IL165027A0 (is)
IS (1) IS7551A (is)
MX (1) MXPA04011990A (is)
NZ (1) NZ537150A (is)
PL (1) PL372071A1 (is)
RS (1) RS106704A (is)
WO (1) WO2003103714A1 (is)
ZA (1) ZA200408892B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
EP1690551A3 (en) * 2005-02-10 2006-10-18 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
CA2597223A1 (en) * 2005-02-10 2006-08-17 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102008011691A1 (de) * 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CN101596159B (zh) * 2008-06-03 2012-12-19 哈药集团生物工程有限公司 一种紫杉醇注射液及其制备方法
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
RS53121B (en) * 2008-11-21 2014-06-30 Boehringer Ingelheim International Gmbh PHARMACEUTICAL COMPOSITION OF POWERFUL HCV INHIBITOR FOR ORAL USE
BR112012000287B8 (pt) 2009-07-07 2021-05-25 Boehringer Ingelheim Int composição farmacêutica para um inibidor de protease viral de hepatite c
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
EP3253401B1 (en) 2015-02-03 2025-04-02 Amryt Endo, Inc. Treating acromegaly with oral octreotide
CN105497905A (zh) * 2015-12-30 2016-04-20 钟术光 一种供注射或口服用的辅料
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用
CN113281425B (zh) * 2021-04-15 2023-06-06 四川汇宇制药股份有限公司 一种聚氧乙烯(35)蓖麻油中游离脂肪酸的检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108823A (en) * 1979-02-13 1980-08-21 Takemoto Oil & Fat Co Ltd Purification of alkylene oxide addition compound
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
JPH02157274A (ja) * 1988-12-07 1990-06-18 Sumitomo Heavy Ind Ltd 植物油からビタミンｅを分離濃縮する方法
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
CA2145190A1 (en) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Use of taxol for treating lymphomas and breast cancer
NZ258044A (en) * 1992-11-27 1995-12-21 Faulding F H & Co Ltd Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent
ES2224200T3 (es) * 1992-11-27 2005-03-01 Mayne Pharma (Usa) Inc. Composicion inyectable estable de paclitaxel.
CA2092271C (en) * 1993-03-09 2009-10-13 Eddie Reed Use of g-csf for treating taxol side-effects
ATE420628T1 (de) * 1993-07-19 2009-01-15 Angiotech Pharm Inc Anti-angiogene mittel und verfahren zu deren verwendung
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE69613273T2 (de) * 1995-04-28 2001-10-31 Loders Croklaan B.V., Wormerveer An polyungesättigten Fettsäuren reiche Triglyceride
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
JP2000044840A (ja) * 1998-07-28 2000-02-15 Mitsubishi Heavy Ind Ltd 燃料ガス漏洩検知塗膜
WO2000023070A1 (en) * 1998-10-20 2000-04-27 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions
EP1262455A4 (en) * 1999-09-22 2006-01-25 Nippon Aerosil Co Ltd SURFACE MODIFIED, FINE SILICONE ACID POWDER AND ITS USE
JP2001247847A (ja) * 2000-03-03 2001-09-14 Nisshin Oil Mills Ltd:The 水性ゲル化剤
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Also Published As

Publication number Publication date
AU2003240661A1 (en) 2003-12-22
HRP20041107A2 (en) 2005-02-28
WO2003103714A1 (en) 2003-12-18
IL165027A (en) 2009-12-24
IL165027A0 (en) 2005-12-18
EP1515751A1 (en) 2005-03-23
CZ294371B6 (cs) 2004-12-15
BR0311687A (pt) 2008-01-15
US20050142225A1 (en) 2005-06-30
PL372071A1 (en) 2005-07-11
CZ20022027A3 (cs) 2004-01-14
ZA200408892B (en) 2006-01-25
MXPA04011990A (es) 2005-08-16
CA2487889A1 (en) 2003-12-18
CN1655824A (zh) 2005-08-17
JP2005534656A (ja) 2005-11-17
RS106704A (en) 2006-12-15
EA007223B1 (ru) 2006-08-25
KR20050010030A (ko) 2005-01-26
EA200401625A1 (ru) 2005-06-30
NZ537150A (en) 2006-09-29

Similar Documents

Publication Publication Date Title
IS7551A (is) Stilltar lyfjafræðilegar samsetningar sem byggðareru á pólýoxýetýlaðri laxerolíu og aðferð við að framleiða þær
NO20031448L (no) Fremgangsmåte for fremstilling av nanopartikler av paclitaxel og albumin
AU2003223207A8 (en) Scds as modifiers of the p53 pathway and methods of use
IS7735A (is) Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
IS7261A (is) N-adamantýlmetýlafleiður og milliefni sem lyfjablöndur og aðferðir til að framleiða þær
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
EP1567089A4 (en) POLYMER STENT AND METHOD FOR PRODUCING THE SAME
IS7467A (is) Lansóprasólfjölgervingar og aðferðir við að framleiða þá
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
AU2003254945A1 (en) Mask and method of producing the same
IS7413A (is) Nýjar 1,2,3,-setnar indólísín afleiður, hindrar af FGFS, aðferð við framleiðslu á þeim og lyfjafræðilegar samsetningar sem innihalda þau
SG116507A1 (en) Pharmaceutical dosage form and method of making.
DE60217416D1 (de) Holzähnliches formteil und sein herstellungsverfahren
AU2003265862A8 (en) Semiconductor component and method of manufacture
PL1608811T3 (pl) Wyrób wielowarstwowy i sposób jego wytwarzania
AU2003275289A8 (en) Polysaccharide-based polymers and methods of making the same
GB2425898B (en) Circuits, multilayer circuits, and method of manufacture thereof
DK3189845T3 (da) Kolesterolsænkende præparat, kosttilskud og fødevare, og fremgangsmåder til fremstilling deraf
SG105589A1 (en) Cube and method of making same
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003294684A8 (en) Ketoprofen compositions and methods of making them
EP1490194A4 (en) TWO-STAGE WELDING MACHINE AND METHOD OF OPERATION
GB0228998D0 (en) Pipe-in-pipe and method of fabrication thereof
AU2003263504A8 (en) Fail-safe method and circuit